Specifically, we found coordinated activities through which Cav1 rewires prostate cancer cells towards exogenous scavenging of sphingomyelin, increased cancer cell catabolism of sphingomyelin to ceramide, and subsequent glycosylation to glycosphingolipid derivatives [13]. Here, CAV1 is linked to cancer.